DMR Logo.png
The U.S. Fertility Market Is Expected To Reach Revenue Of Usd 8.7 Bn By 2033, At 5.1% CAGR: Dimension Market Research
09 déc. 2024 09h01 HE | Dimension Market Research
New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview The U.S. Fertility Market is projected to reach USD 5.6 billion in 2024 which is further anticipated to reach USD 8.7 billion by 2033 at a CAGR...
Intrauterine Devices Market
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT International
04 déc. 2024 07h38 HE | Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Intrauterine Devices Market Report Forecast by Type, End-use, Countries and Company Analysis 2024-2032" report has been added to ...
Male Infertility Market
Male Infertility Business Research Report 2024: Global Market to Reach $6.5 Billion by 2030 - Focus on Reducing Stigma and Increasing Access Strengthens Growth Prospects
19 nov. 2024 09h04 HE | Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Male Infertility - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Male Infertility...
22157.jpg
2024 Research Report | Contraceptive Drugs Market Poised for Expansion, Predicted to Reach USD 12.47 Billion by 2030
30 oct. 2024 11h28 HE | Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
myriad_S_stacked.png
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
16 oct. 2024 09h00 HE | Myriad Genetics, Inc.
Myriad Genetics announced a strategic partnership with jscreen to advance health equity and genetic testing access.
sns insider pvt ltd.png
Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
15 oct. 2024 09h10 HE | SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...
United Kingdom Pregnancy Testing Kits Market
£302+ Million UK Pregnancy Testing Kits Market Forecast, 2029: Heightened Awareness, Convenience, and Technological Innovations Driving Industry Growth, Dominated by the South-East
10 oct. 2024 04h17 HE | Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Pregnancy Testing Kits Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Pregnancy Detection Kits Market
Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel
08 oct. 2024 04h03 HE | Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Pregnancy Detection Kits - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pregnancy...
Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
30 sept. 2024 11h29 HE | American College of Medical Toxicology
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
U.S. Women’s Health Market
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
20 sept. 2024 04h04 HE | Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...